@FierceMedDev: New radiation therapy companion Dx in the works. More | Follow @FierceMedDev
@MarkHFierce: Roche's diagnostics division sales fell flat in Q1. Dx tests sold well, but its diabetes arm tanked. Story | Follow @MarkHFierce
@DamianFierce: We read the FDA's budget request so you don't have to: The agency wants an 11% raise for device approvals. Article | Follow @DamianFierce
> Critical Diagnostics, which develops cardiovascular disease-related biomarkers, has inked new distribution deals in Italy, Russia, Isreland, Bulgaria, the U.K., Slovenia, Croatia and Serbia, Sweden, Belgium and the Netherlands. Item
> Covidien ($COV) has signed a deal to distribute Vida Diagnostics' pulmonary imaging software devices. Release
> Avioq won a CE mark for its human T-lymphotropic virus assay, testing for a leukemia-related ailment. The diagnostic is already FDA approved. News
> Maquet Cardiovascular nailed down both FDA 510(k) clearance and a CE mark in Europe for a new radial compression device designed to stop bleeding after a radially accessed coronary catheterization procedure. Release
> Sanuwave Health said it has secured a U.S. patent to use external shock waves in a blood sterilization technique. Item
> CD Diagnostics will be spotlighted on an April 15 episode the Discovery Channel's "Health Heroes," which will focus on orthopedic innovations. Story
Biotech News
@FierceBiotech: Still trending: Analysts rank the top 10 blockbuster duds in biopharma. Article | Follow @FierceBiotech
@JohnCFierce: Everywhere in the world Big Pharma cuts pretty much as it pleases. Sanofi in France? No way. No how. WSJ Report | Follow @JohnCFierce.
@RyanMFierce: In case you missed last night: J&J, Roche and others back platform to bolster translational drug research. Article | Follow @RyanMFierce
> Omthera discounts IPO shares, prices at $8. Item
> NEA, Pfizer build a launch pad for a portfolio of orphan-drug biotechs. News
> GlaxoSmithKline stakes a pioneering effort to launch 'electroceutical' R&D. Report
> Bristol-Myers maps $250M manufacturing expansion to support growing R&D effort. Story
Pharma News
@FiercePharma: Roche's Avastin delivered in the first quarter, too: 11% growth, to 1.53B francs, almost back to 2010 levels. | Follow @FiercePharma
@EricPFierce: FDA did 813 inspections in 62 countries last year, but it says it needs even more money to keep up. Story | Follow @EricPFierce
> President's budget takes a big bite out of Medicare drug spending. News
> Pharma reps aren't talking about drug risks, study finds. Report
Pharma Manufacturing News
> FDA nails Pfizer plant for contaminated Torisel diluent. News
> Sanofi plant ramps up malaria treatment with cutting-edge technology. Article
> FDA budget would expand China office. Story
> Hamburg to face Congress again over compounding lapses. Report
> Mylan Napa plant to close by year-end. Article
Vaccines News
> U.S. works with Inovio in prep for bioterrorism vaccinations. Article
> China expects H7N9 vaccine in 7 months. Item
> Ovarian cancer vax makes good start on long slog to approval. Story
> Negative vaccine views spread like viruses on Twitter. Article
> H7N9 an early test for revised U.S. pandemic preparations. Report